17-epi-Ethynyl Estradiol is a stereoisomer of the widely used synthetic estrogen, ethinyl estradiol. Its chemical name is (8R,9S,13S,14S,17S)-17-ethynyl-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol. This compound differs from the active pharmaceutical ingredient (API) in the configuration at the C17 position. This compound is primarily recognized and utilized as a specified impurity or reference standard in the pharmaceutical industry. It is a key process-related impurity or degradation product that must be monitored and controlled during the manufacturing and quality control of ethinyl estradiol and its combination drug products, such as oral contraceptives and hormone replacement therapies. Analytical methods, including HPLC, are developed and validated using this standard to ensure the purity, safety, and efficacy of the final drug product. As a well-defined chemical entity related to a major API, it falls under the category of pharmaceutical impurities and reference standards. Its primary value lies in analytical chemistry and regulatory compliance for drug development and production, rather than as a therapeutic agent or a general-purpose synthetic building block.